Hi! I'm Orris. How can I help you today?

Tell the topic integrated counselling and testing centre in detail in story form so that i can remember easily

Reading File

Finding Sources

Searching the Web

Integrated Counselling and Testing Centre ICTC HIV India details functions

Finding Sources

Reading Web Page

https://www.tnsacs.in/ictc

Reading File

I now have all the information I need. Let me craft a detailed, story-form explanation that makes this topic easy to remember.

The Story of "Asha's Gateway" - Understanding ICTC

(Based on Park's Textbook of Preventive and Social Medicine)

Chapter 1: The Village That Feared a Shadow

In a small town in India, lived a young woman named Asha. She had heard whispers about HIV but was too scared to ask questions or get tested. She didn't know where to go, who to trust, or whether anyone would keep her secret.

One day, a doctor at the local hospital said, "Asha, there is a special place made just for people like you. It is called the Integrated Counselling and Testing Centre - the ICTC."

Chapter 2: What Is the ICTC? The "Gateway"

The ICTC is India's front door for HIV services - a safe, free, confidential place where anyone can walk in and get:

Information about HIV
Counselling (emotional support + guidance)
HIV testing

It was started by India's National AIDS Control Programme (NACP) with a single mission: Find HIV-positive people as early as possible, and link them to care before it's too late.

The programme has been running since 1997, and got a massive boost in 2004 when India introduced free ART (antiretroviral therapy).

Think of ICTC as the gateway - you enter scared and confused, and leave with answers, support, and a path forward.

Chapter 3: Who Comes to ICTC? Two Kinds of Visitors

When Asha arrived at the ICTC, she saw two kinds of people:

Client-Initiated (CITC): People like Asha who came on their own free will, worried about possible exposure to HIV.
Provider-Initiated (PITC): People sent by their doctor - for example, a TB patient whose doctor suspected HIV co-infection, or a pregnant woman whose midwife referred her.

Both types are equally welcome. No one is judged.

Chapter 4: The Three Functions Asha Discovered

Inside the ICTC, Asha learned its three core functions:

1. Early Detection

HIV testing is done - reliably and confidentially. The sooner HIV is found, the better the outcome.

2. Education & Behavior Change

Asha was told about how HIV spreads (blood, sexual contact, mother-to-child) and how to protect herself and her family. The counsellor helped Asha understand risk and reduce it.

3. Linkage to Care

When results came out, the counsellor linked Asha - and HIV-positive clients - to ART centres, PPTCT services, TB clinics, and social welfare schemes. The ICTC doesn't just test; it connects.

Chapter 5: The Four Types of ICTC - Four Rooms in the Same House

As Asha's story spread, she learned that ICTCs exist in different forms to reach everyone:

Room 1 - Standalone ICTC (SA-ICTC) 🏥

The Big Hospital Version

Located in: Medical colleges, District hospitals, Sub-district hospitals, CHCs
High client load
Full-time dedicated Counsellor + Lab Technician
Extra counsellor added if >500 counsellings/month
Extra lab technician for every 5,000 additional annual tests (max 3 LTs)
Performs: Pre-test counselling, HIV testing (confirmatory), post-test counselling, EID (Early Infant Diagnosis), STI/RTI screening, TB screening, partner testing, linkage to all services

Think: "The SA is the Senior Centre" - big, busy, fully staffed.

Room 2 - Facility-Integrated ICTC (F-ICTC) 🏪

The Embedded Version

Located below block level - at 24x7 PHCs (Primary Health Centres)
NOT a separate building - woven into the existing health facility
Existing health staff are trained to provide HIV counselling and testing
Logistics (test kits, IEC materials, protective kits, PEP drugs) supplied by DAC (Department of AIDS Control)
Also extended to private facilities through PPP-ICTC (Public-Private Partnership)

Think: "F-ICTC is like a shop-within-a-shop" - HIV services built into an already existing PHC.

Room 3 - Mobile ICTC 🚐

The Van That Goes to You

For those living in remote, hard-to-reach areas who cannot come to a facility, the ICTC comes to them - on wheels!

A specially equipped van carries:

A room for general examination
Space for counselling
Space for blood collection and processing

Staffed by: Health educator/ANM + Counsellor + Lab Technician

Services offered:

HIV counselling and testing
Syndromic management of STI/RTI
Antenatal care
Immunization services
General health check-ups

Think: "Mobile ICTC = The hospital bus that parks in your village"

Room 4 - Community-Based HIV Screening 👩‍⚕️

The Frontline Worker Version

At the sub-centre level, ANMs (Auxiliary Nurse Midwives) go door-to-door to offer HIV testing, especially to pregnant women - to prevent mother-to-child transmission.

Chapter 6: ICTC and the Pregnant Woman - PPTCT

When Asha became pregnant years later, she remembered the ICTC. This time, she went not just for herself but for her baby.

India has over 15,000 ICTCs that offer PPTCT (Prevention of Parent-to-Child Transmission) services. Every pregnant woman is offered HIV counselling and testing with an "opt-out" option.

If found HIV-positive:

She receives multi-drug ART (triple therapy) regardless of CD4 count
Her husband is involved in counselling
Her newborn gets prophylaxis
Breastfeeding guidance is given

India moved from single-dose Nevirapine (up to 2012) → multi-drug ART (from Sept 2012 in southern states) → lifelong ART for all HIV+ pregnant women (from 2013 onward, following WHO guidelines).

Chapter 7: ICTC and TB - Two Old Enemies

One of Asha's neighbors had TB. At the ICTC, he learned that India has a National Technical Working Group on TB/HIV that mandates:

HIV screening for ALL TB patients at ICTCs
TB screening for ALL HIV-positive people at ICTCs
Whole blood finger-prick HIV test available at all DMCs (Directly Observed Treatment Centres)

Remember: TB and HIV are frenemies - one makes the other worse. ICTC screens for both.

Chapter 8: The Staff of ICTC - The Three Pillars

Every SA-ICTC runs on three people:

Person	Role
Medical Officer (In-Charge)	Oversees the centre, clinical decisions
Counsellor (contractual)	Pre-test counselling, informed consent, post-test counselling, disclosure support, follow-up
Lab Technician (contractual)	HIV testing, EID, quality assurance

Quick Memory Trick - "ICTC = I Can Test Confidentially"

Letter	Stands For
I	Integrated - brings HIV counselling, testing, and linkage together
C	Confidential - everything is private
T	Testing - HIV diagnosis done here
C	Centre - a physical or mobile space

The Final Summary Table

Feature	Details
Started	1997
Boost	2004 (ART launch)
Types	SA-ICTC, F-ICTC, Mobile ICTC, Community-based
Who can come	Anyone (voluntary or provider-referred)
Core functions	Early detection, education, linkage to care
Key services	HIV test, counselling, PPTCT, TB-HIV, STI/RTI, EID, partner testing
Staff (SA-ICTC)	Medical Officer + Counsellor + Lab Technician
Total ICTCs in India	>15,000

Source: Park's Textbook of Preventive and Social Medicine, pp. 491-492

Asha's story ends with her healthy, her baby HIV-free, and her community educated. All because one gateway existed - the ICTC.

Remove the story format now n also provide image

Searching Images

Integrated Counselling and Testing Centre ICTC HIV services diagram

This clinical photograph captures a community-based medical outreach event focused on HIV testing and counseling in a low-resource or rural setting. The scene is organized under a temporary white canopy tent, providing a designated area for medical services. A prominent banner displays the text 'Free HIV Testing & Counseling,' indicating the primary public health objective. A healthcare worker, identifiable by blue clinical attire and protective gloves, is seated at a table covered with medical papers and testing materials, actively engaging with community members. The demographic depicted includes a diverse group of adults, both male and female, dressed in a variety of traditional head coverings and casual clothing, suggesting a culturally integrated approach to healthcare delivery. The setting emphasizes the concept of 'commonization' of HIV services by bringing diagnostic and counseling resources directly into hard-to-reach communities to improve accessibility and universal health coverage. The presence of individuals waiting in proximity to the testing station illustrates provider-initiated counseling and testing (PITC) in an informal, community-integrated environment.

This infographic illustrates the Infomóvel program functionalities, a mobile-based healthcare delivery system designed to improve HIV and TB patient retention and care in community settings. The diagram outlines a collaborative framework between three main domains: Community, Health Facility, and the digital CommCare platform. Four key roles are identified: 1) Index Patients, categorized as treatment defaulters (Index Patient 1) or newly diagnosed individuals (Index Patient 2); 2) Activista (Community Health Worker), who conducts household visits for counseling, TB/malnutrition screening, and testing of co-habitants; 3) Case Manager at the Health Facility, responsible for patient registration, consenting for tracking, and verifying patient lists; and 4) Supervisor, who provides performance monitoring and technical support to the Activistas. Centrally, the Activista uses a mobile device to sync patient data to the CommCare platform, facilitating a closed-loop referral system. The diagram emphasizes integrated disease management for HIV and TB, linking community-based active case finding with health facility-based treatment adherence strategies.

WHO-recommended collaborative TB/HIV activities <table><thead><tr><th colspan="2">WHO-recommended collaborative TB/HIV activities</th></tr></thead><tbody><tr><td>A.</td><td>Establish and strengthen the mechanisms for delivering integrated TB and HIV services</td></tr><tr><td>A.1.</td><td>Set up and strengthen a coordinating body for collaborative TB/HIV activities functional at all levels</td></tr><tr><td>A.2.</td><td>Determine HIV prevalence among TB patients and TB prevalence among people living with HIV</td></tr><tr><td>A.3.</td><td>Carry out joint TB/HIV planning to integrate the delivery of TB and HIV services</td></tr><tr><td>A.4.</td><td>Monitor and evaluate collaborative TB/HIV activities</td></tr><tr><td>B.</td><td>Reduce the burden of TB in people living with HIV and initiate early antiretroviral therapy (the Three I's for HIV/TB)</td></tr><tr><td>B.1.</td><td>Intensify TB case-finding and ensure high quality antituberculosis treatment</td></tr><tr><td>B.2.</td><td>Initiate TB prevention with Isoniazid preventive therapy and early antiretroviral therapy</td></tr><tr><td>B.3.</td><td>Ensure control of TB infection in health-care facilities and congregate settings</td></tr><tr><td>C.</td><td>Reduce the burden of HIV in patients with presumptive and diagnosed TB</td></tr><tr><td>C.1.</td><td>Provide HIV testing and counselling to patients with presumptive and diagnosed TB</td></tr><tr><td>C.2.</td><td>Provide HIV prevention interventions for patients with presumptive and diagnosed TB</td></tr><tr><td>C.3.</td><td>Provide co-trimoxazole preventive therapy for TB patients living with HIV</td></tr><tr><td>C.4.</td><td>Ensure HIV prevention interventions, treatment and care for TB patients living with HIV</td></tr><tr><td>C.5.</td><td>Provide antiretroviral therapy for TB patients living with HIV</td></tr></tbody></table>

This pathophysiology diagram illustrates the viral superinfection and co-infection dynamics within a CD4+ T cell latently infected with HIV-1. The top section presents various superinfecting viruses: HIV-1 subtypes, HIV-2, HTLV-1/2, HSV-1, HHV-6/7, GBV-C, and SARS-CoV-2. Each virus is depicted with its specific morphology, accompanied by text boxes detailing clinical outcomes such as pseudotyping, generation of recombinant forms (CRFs/URFs), and modulation of HIV-1 replication (e.g., HIV-2 and GBV-C mediated inhibition versus HSV-1 mediated promotion). The central portion shows the T cell membrane featuring CD4 receptors and CCR5/CXCR4 co-receptors. The lower section focuses on the nucleus, showing host genomic DNA (yellow double helix) with integrated HIV-1 provirus DNA (blue/black double helix). The molecular architecture of the HIV-1 5' Long Terminal Repeat (LTR) is highlighted between nucleosomes Nuc 0 and Nuc 1, representing the site for potential transcriptional reactivation following superinfection. The diagram effectively summarizes how secondary viral infections can influence HIV-1 pathogenesis and the latent reservoir.

Loading Image

Here is the complete, structured notes on Integrated Counselling and Testing Centre (ICTC) with the textbook diagram:

Integrated Counselling and Testing Centre (ICTC)

Definition

ICTC is a place where HIV Counselling and Testing Services (HCTS) are provided to an individual either of their own will (Client-Initiated - CITC) or as suggested by a medical care provider (Provider-Initiated - PITC).

Background

HIV counselling and testing services in India started in 1997 under the National AIDS Control Programme (NACP)
Managed by the Basic Service Division, Department of AIDS Control (DAC)
Goal: Identify HIV-positive people as early as possible and link them to prevention, care, and treatment
Introduction of ART services in 2004 gave a major boost to ICTC services
Currently more than 15,000 ICTCs in India

Three Core Functions of ICTC

Early detection of HIV infection
Provision of basic information on modes of transmission and prevention of HIV/AIDS to promote behavioral change and reduce vulnerability
Linkage of PLHIV (People Living with HIV) to other HIV prevention, care, and treatment services

Types of ICTC

Level-wise Structure (from the textbook diagram below)

Levels of HIV counselling and testing services in India - Park's Textbook

A. Fixed Facility ICTCs

Located within an existing healthcare facility/hospital/health centre. Two sub-types:

1. Standalone ICTC (SA-ICTC)

Feature	Details
Location	Medical colleges, District hospitals, Sub-district hospitals, CHCs
Client load	High
Staff	Medical Officer (in-charge) + Counsellor + Lab Technician (both contractual)
Extra counsellor	If >500 counsellings/month
Extra LT	Every additional 5,000 annual tests; max 3 LTs

Services at SA-ICTC:

Pre-test counselling and informed consent
HIV testing and sharing of results
Post-test counselling and disclosure support
Early Infant Diagnosis (EID)
Testing of sexual partner/spouse
Screening for STI/RTI, TB, and other co-infections
Linkage to care, treatment, and other health services
Linkage to social welfare schemes
Outreach activity
Follow-up testing and counselling
Follow-up of discordant couples
Acts as nodal point for coordination, supervision, capacity building, and supply chain management of all F-ICTCs

2. Facility-Integrated ICTC (F-ICTC)

Feature	Details
Location	Below block level - 24x7 PHCs
Concept	HIV services embedded into existing health facility (not a separate building)
Staff	Existing health facility staff trained in HIV counselling and testing
Logistics support	Provided by DAC (test kits, IEC materials, PEP drugs, protective kits)
PPP-ICTC	Extended to private hospitals, labs, NGOs under Public-Private Partnership

B. Mobile ICTC

A van equipped with:

Room for general examination
Counselling space
Blood collection and processing area

Staff: Health educator/ANM + Counsellor + Lab Technician

Target: Hard-to-reach areas with flexible working hours

Services:

HIV counselling and testing
Syndromic management of STI/RTI
Antenatal care
Immunization services
General health check-ups

C. Community-Based HIV Screening

Conducted by Auxiliary Nurse Midwives (ANMs) at the sub-centre level
Goal: Offer HIV testing to every pregnant woman in the country
To detect all HIV-positive pregnant women and eliminate parent-to-child transmission

Staff Pattern (SA-ICTC Summary)

Staff	Appointment	Criteria
Medical Officer	In-charge	1 per centre
Counsellor	Contractual	1 (additional if >500/month)
Lab Technician	Contractual	1 (additional per 5,000 tests; max 3)

ICTC and TB-HIV Coordination

HIV screening done for ALL individuals at ICTC (irrespective of HIV status - including TB patients)
TB screening done for ALL HIV-positive cases at ICTC
National Technical Working Group on TB/HIV mandates whole blood finger-prick HIV test at all DMCs (DOTS Microscopy Centres) without a standalone or F-ICTC
Provider-Initiated HIV Testing and Counselling (PITC) done for all presumptive TB cases

ICTC and PPTCT (Prevention of Parent-to-Child Transmission)

PPTCT programme started in 2002 in India
All >15,000 ICTCs offer PPTCT services to pregnant women
Every pregnant woman is offered HIV testing with an "opt-out" option
Evolution of treatment strategy:
- Up to 2012: Single-dose Nevirapine (SD-NVP)
- Sept 2012: Multi-drug ARV prophylaxis (Option B - WHO 2010)
- From 2013: Lifelong ART (triple drug regimen) for all HIV-positive pregnant and breastfeeding women regardless of CD4 count or WHO clinical stage

Key Points to Remember

Feature	Fact
Started	1997
ART boost year	2004
Total ICTCs in India	>15,000
Types	SA-ICTC, F-ICTC, Mobile ICTC, Community-based
Entry modes	Client-initiated (CITC) or Provider-initiated (PITC)
TB screening	Done for ALL at ICTC (not just HIV-positive)
PPTCT started	2002
Current PPTCT regimen	Lifelong triple ART (from 2013)

Source: Park's Textbook of Preventive and Social Medicine, pp. 491-492

Tell me about imnci in detail

Finding Sources

Searching the Web

IMNCI integrated management neonatal childhood illness India components strategy

Finding Sources

Reading Web Page

https://ihatepsm.com/blog/integrated-management-neonatal-and…

Reading File

Loading Image

Here is the complete, structured notes on IMNCI:

Integrated Management of Neonatal and Childhood Illness (IMNCI)

Definition

IMNCI is an integrated approach to child health that focuses on the well-being of the whole child. It was developed by WHO and UNICEF to reduce mortality and morbidity in children under 5 years from common illnesses such as diarrhoea, ARI, malaria, measles, and malnutrition.

The Indian version of IMCI was renamed IMNCI - adding "Neonatal" because India included the first 0-7 days of life in the programme.
It is the central pillar of child health interventions under the RCH-II/NRHM strategy.

Why IMNCI?

Most sick children present with signs of more than one illness simultaneously. A single diagnosis is often not possible or appropriate. IMNCI takes an integrated approach because:

ARI - 17% of children under 3 years (NFHS-III)
Fever - 27%
Under-nutrition - 43%
Diarrhoea - 13%
Measles vaccination coverage was also low

Addressing these separately is costly and inefficient. IMNCI combines prevention, promotion, and curative care together.

Indian Adaptations (IMNCI vs. IMCI)

Feature	IMCI (WHO original)	IMNCI (Indian version)
Age coverage	1 week to 5 years	0-7 days included (neonatal period)
Malaria guidelines	Generic	National guidelines incorporated
Anaemia/Vit A	Not specific	National guidelines included
Immunization	Generic	India's national schedule
Training focus	More on sick child	Equal time for sick young infant and sick child
Skill basis	Yes	Yes - skill-based training

Three Core Components of IMNCI Strategy

1. Improve Case-Management Skills of Health Staff

Training of frontline health workers (Medical Officers, Nurses, ANMs, LHVs) using IMNCI guidelines and wall charts
Emphasis on correct assessment, classification, and treatment

2. Strengthen the Overall Health System

Ensure supply chain of drugs and supplies
Improve referral systems
Strengthen supervision and quality assurance

3. Improve Family and Community Health Care Practices

Teach families when to seek care
Promote correct home management
Improve care-seeking behaviour
Community involvement in prevention and follow-up

IMNCI Case Management Process (6 Steps)

Step 1 - ASSESS

Take history + perform physical examination
Check for general danger signs first

Step 2 - CLASSIFY

Assign a colour-coded classification (not a specific disease diagnosis) based on severity:

Colour	Meaning	Action
🔴 PINK	Severe/emergency	Urgent referral to hospital
🟡 YELLOW	Moderate	Treatment at outpatient facility
🟢 GREEN	Mild	Home management with advice

Step 3 - IDENTIFY TREATMENT

Charts recommend specific treatment for each classification

Step 4 - TREAT

Give treatment in clinic, prescribe drugs or home treatments
Teach the caregiver

Step 5 - COUNSEL THE MOTHER/CAREGIVER

Feeding, fluids
When to return immediately (danger signs)
Home care instructions

Step 6 - FOLLOW-UP CARE

Plan timely follow-up visit
Refer if needed
Reassess for new problems at follow-up

IMNCI Flowchart (from Park's Textbook)

IMNCI Integrated Case Management Process Flowchart - Park's Textbook

Two Age Groups with Separate Wall Charts

Group 1: Young Infant (0 up to 2 months)

Two charts:

Assess and Classify the Sick Young Infant (up to 2 months)
Treat the Young Infant and Counsel the Mother

Conditions assessed:

Possible bacterial infection / local bacterial infection
Jaundice
Diarrhoea
Feeding problems / Low weight
Pneumonia

Follow-up needed for: Pneumonia, Local bacterial infection, Jaundice, Diarrhoea with some dehydration, Feeding problem or Low weight

Group 2: Sick Child (2 months up to 5 years)

Three charts:

Assess and Classify the Sick Child (2 months to 5 years)
Treat the Child
Counsel the Mother

Conditions assessed:

Cough / Difficulty breathing
Diarrhoea
Fever
Ear problems
Malnutrition and Anaemia
Immunization status
Development assessment

General Danger Signs (Check FIRST in children 2 months - 5 years)

Any one of the following = PINK classification = Urgent Referral:

Not able to feed or drink
Vomits everything
Lethargic or unconscious
Convulsions (present now or history)

Treatment at Each Level

Level	Action
Outpatient Health Facility (Pink)	Pre-referral treatment → Advise parents → Refer child URGENTLY
Referral Facility	Emergency Triage and Treatment (ETAT) → Diagnosis → Treatment → Monitoring → Follow-up
Outpatient Health Facility (Yellow)	Treat local infection, give oral drugs, advise and teach caregiver, follow-up
Home (Green)	Counsel caregiver - give oral drugs, treat local infections at home, continue feeding, return signs, follow-up

IMNCI Variants

Pre-Service IMNCI

Being included in the curriculum of medical colleges across India
Provides trained IMNCI manpower for both public and private sectors

Facility-Based IMNCI (F-IMNCI)

Integration of facility-based care with IMNCI package
Empowers health personnel to manage newborns and childhood illness at both community and facility level
Focuses on inpatient management of:
- Asphyxia
- Sepsis
- Low birth weight
- Pneumonia
- Diarrhoea
- Malaria
- Meningitis
- Severe malnutrition
Master trainers: Paediatricians from tertiary hospitals and medical colleges

Implementation at Various Levels

Level	Who implements
Household	IMNCI package delivered at home level
Sub-centre	ANMs trained in IMNCI
PHC	Medical Officers, Nurses, LHVs
CHC/FRU	F-IMNCI - Newborn Stabilization Unit (NBSU)
District Hospital	F-IMNCI - Special Newborn Care Unit (SNCU)

Newborn Care Facilities under F-IMNCI

Facility	Level	For all newborns	For sick newborns
PHC/Sub-centre (MCH Level I)	Primary	Newborn Care Corner (NBCC) in labour room	Prompt referral
CHC/FRU (MCH Level II)	Secondary	NBCC in labour room + OT	Newborn Stabilization Unit (NBSU) - 4 bedded
District Hospital (MCH Level III)	Tertiary	NBCC in labour room + OT	Special Newborn Care Unit (SNCU)

NBCCs operational in India: ~20,336
NBSUs functional: ~2,421

Important Note on Limitations

IMNCI guidelines do NOT cover:

Trauma or acute emergencies from accidents/injuries
AIDS specifically (though common HIV presentations like diarrhoea and respiratory infections are managed the same way)
Chronic problems or less common illnesses (these require special/referral care)

Quick Summary

Feature	Details
Developed by	WHO + UNICEF
Indian version name	IMNCI (adds neonatal 0-7 days)
Age group covered	0 days to 5 years
Under which programme	RCH-II / NRHM
Core approach	Assess → Classify → Treat → Counsel → Follow-up
Colour coding	Pink (referral), Yellow (treat), Green (home)
Key target illnesses	ARI, Diarrhoea, Malaria, Measles, Malnutrition
3 main components	Case management skills + Health system + Family/community practices

Source: Park's Textbook of Preventive and Social Medicine, pp. 516-522

Now tell me in story form

The Story of Dr. Meera and the Village of Sick Children

Chapter 1: The Problem That Couldn't Be Ignored

In a small village in rural India, a young doctor named Dr. Meera had just been posted at the Primary Health Centre. On her very first week, she saw something that disturbed her deeply.

A mother rushed in with her 3-year-old son Raju, who had a cough, loose stools, AND a fever - all at once.

Dr. Meera opened her old textbook and found three separate chapters - one for ARI, one for diarrhoea, one for fever. She treated each one separately, wrote three prescriptions, and sent the mother home confused with a fistful of medicines.

The next day, another child came. Then another. All with multiple problems at the same time.

Dr. Meera thought - "There must be a better way. These children don't have just one disease. They have everything together."

And that is exactly why IMNCI was born.

Chapter 2: WHO and UNICEF Step In - The Birth of IMCI (and then IMNCI)

The World Health Organisation and UNICEF had already noticed this problem worldwide. They created a strategy called IMCI - Integrated Management of Childhood Illness - a single, unified approach to manage ALL common childhood illnesses together.

India adopted it - but with one important addition.

Indian doctors said: "Wait - what about newborns? The first 7 days of life are the most dangerous. We must include them too."

So India renamed it IMNCI - Integrated Management of Neonatal and Childhood Illness - adding the "N" for Neonatal, covering children from Day 0 all the way to 5 years.

India also added:

Its own national malaria guidelines
Its own anaemia and Vitamin A protocols
Its own immunization schedule
Equal training time for sick newborns AND sick older children

IMNCI became the central pillar of child health under India's RCH-II / NRHM programme.

Chapter 3: Why Was It So Urgently Needed? - The Numbers That Shocked India

When the NFHS-III report came out, the data was alarming for children under 3 years:

Problem	% of Children Affected
Under-nutrition	43%
Fever	27%
ARI (cough/breathing difficulty)	17%
Diarrhoea	13%

Plus - measles vaccination coverage was embarrassingly low.

Dr. Meera read this and understood - "We can't keep treating one disease at a time. We need a system."

Chapter 4: The Three Pillars - IMNCI's Master Plan

IMNCI rests on three strong pillars. Think of them as three legs of a stool - remove any one and it falls.

Pillar 1 - Train the Doctors and Health Workers

Dr. Meera herself underwent training. She learned standardized guidelines - how to assess ANY sick child systematically, how to classify severity, and how to treat correctly. ANMs, nurses, and LHVs were trained too.

Pillar 2 - Fix the Health System

What good is a trained doctor if there are no medicines on the shelf? IMNCI made sure the supply chain, referral systems, and supervision were all strengthened.

Pillar 3 - Educate the Family

Dr. Meera's training taught her that a child dies not just because the doctor was wrong - but often because the mother brought the child too late, or went to an untrained provider. So IMNCI made family education a core part of the programme. Teach mothers the danger signs. Teach them when to come immediately. Teach them correct home care.

Chapter 5: The Two Children - Two Different Charts

Back at her PHC, Dr. Meera learned that IMNCI divides children into two age groups, each with its own set of wall charts displayed prominently in her clinic.

Child A: Baby Sona - 3 weeks old (Young Infant: 0 to 2 months)

Baby Sona came in with fast breathing and not feeding well.

Dr. Meera used Chart Set 1 (for young infants):

"Assess and Classify the Sick Young Infant"
"Treat the Young Infant and Counsel the Mother"

Child B: Raju - 3 years old (Sick Child: 2 months to 5 years)

Raju came back with cough, diarrhoea, and fever.

Dr. Meera used Chart Set 2 (for sick children):

"Assess and Classify the Sick Child"
"Treat the Child"
"Counsel the Mother"

Chapter 6: The Six Steps Dr. Meera Follows Every Time

For every sick child who walks in, Dr. Meera follows 6 steps like clockwork:

Step 1 - ASSESS

She takes a history and examines the child thoroughly. For Raju, she checks:

Danger signs first
Cough and breathing
Diarrhoea
Fever
Ear problems
Nutrition and immunization status

Step 2 - CLASSIFY (The Colour Code System)

This is IMNCI's most clever innovation. Dr. Meera does NOT give a single disease diagnosis. She assigns a colour based on severity:

🔴 PINK = Severe → Urgent hospital referral needed 🟡 YELLOW = Moderate → Treat at the outpatient facility 🟢 GREEN = Mild → Send home with careful advice

Step 3 - IDENTIFY TREATMENT

The chart tells Dr. Meera exactly what treatment matches each colour classification.

Step 4 - TREAT

She gives treatment in the clinic, prescribes medicines, or arranges urgent referral.

Step 5 - COUNSEL THE MOTHER

She sits with Raju's mother and explains:

How to give medicines at home
What foods to continue giving
The danger signs - when to bring Raju back immediately:
- Cannot drink or feed
- Vomiting everything
- Convulsions
- Becomes lethargic or unconscious

Step 6 - FOLLOW-UP

She tells the mother: "Come back in 2 days. If anything gets worse before that, come immediately."

Chapter 7: The Pink Child - The Emergency

One afternoon, a mother ran in screaming. Her 18-month-old daughter Priya was limp, not responding, and had been convulsing at home.

Dr. Meera checked immediately - Priya had ALL four general danger signs:

Could not drink
Vomiting everything
Lethargic and unconscious
Convulsing

Dr. Meera stamped Priya's chart PINK without hesitation.

She gave pre-referral treatment - first dose of medicines to stabilize Priya, explained the situation to the family, and sent her urgently to the District Hospital.

At the District Hospital, the team performed ETAT (Emergency Triage and Treatment), diagnosed bacterial meningitis, treated, and monitored Priya carefully.

Priya survived. Because the system worked.

Chapter 8: F-IMNCI - When the Facility Steps Up

As months passed, more and more sick children were being identified at the PHC level through IMNCI and referred upward. The hospitals needed to be ready.

This is where F-IMNCI (Facility-Based IMNCI) came in - the hospital-level version of IMNCI.

F-IMNCI trains paediatricians and medical officers at higher facilities to manage the most serious newborn and childhood conditions as inpatients:

Birth asphyxia
Neonatal sepsis
Low birth weight
Severe pneumonia
Severe diarrhoea
Malaria
Meningitis
Severe malnutrition

Master trainers - paediatricians from tertiary hospitals and medical colleges - trained teams at state and district level.

Chapter 9: The Newborn Care Ladder

Dr. Meera also learned that India set up a three-tier system for newborn care under F-IMNCI:

Tier 1 - PHC/Sub-centre (MCH Level I)

A Newborn Care Corner (NBCC) is MANDATORY in every labour room - a designated space to provide immediate care to ALL newborns at birth. India has over 20,336 NBCCs operational. "For routine newborns - and prompt referral for sick ones."

Tier 2 - CHC/FRU (MCH Level II)

A Newborn Stabilization Unit (NBSU) - a 4-bedded unit where sick and low birth weight newborns can be stabilized. India has ~2,421 NBSUs functional. "For newborns who need short-term care before going higher."

Tier 3 - District Hospital (MCH Level III)

A Special Newborn Care Unit (SNCU) - for critically sick newborns needing intensive care. "The top of the ladder - for the sickest babies."

Chapter 10: Pre-Service IMNCI - Teaching Future Doctors

The Government of India realized something important - why wait to train doctors after they graduate?

Pre-service IMNCI was built into the curriculum of medical colleges across India. Now every medical student learns IMNCI before they even step into practice.

Dr. Meera thought - "If I had learned this in college, I would have known exactly what to do with Raju on Day 1."

Chapter 11: What IMNCI Does NOT Cover

Dr. Meera kept this in mind:

IMNCI has limits. It does not cover:

Road accidents or trauma
Chronic illnesses
Less common rare diseases
AIDS specifically (though HIV children with diarrhoea/ARI are managed the same way; if they don't respond to standard treatment or become severely malnourished, they are referred to hospital)

The Final Memory Map

Element	Key Fact
Developed by	WHO + UNICEF
Indian name	IMNCI (added Neonatal - Day 0 to 7 days)
Age covered	0 to 5 years
Programme	RCH-II / NRHM
3 Pillars	Train staff + Strengthen system + Family education
2 Chart sets	Young infant (0-2 months) + Sick child (2 months-5 years)
3 Colours	Pink (refer) + Yellow (treat) + Green (home)
6 Steps	Assess → Classify → Identify → Treat → Counsel → Follow-up
4 Danger signs	Can't feed, Vomits all, Lethargic, Convulsions
F-IMNCI	Hospital-level care for serious cases
Newborn ladder	NBCC → NBSU → SNCU

Dr. Meera never again felt lost with a sick child. IMNCI gave her a system - and that system saved lives.

(Source: Park's Textbook of Preventive and Social Medicine, pp. 516-522)

Create a visual guide showing IMNCI assessment flowcharts

Reading File

Running Command

ls -la /tmp/workspace/ 2>/dev/null || mkdir -p /tmp/workspace && echo "created"

Janani suraksha yojana in story format n all help me to remember by cisulizing image

Finding Sources

Searching the Web

Janani Suraksha Yojana JSY India cash incentive eligibility categories details

Reading File

Searching Images

Janani Suraksha Yojana JSY maternal health India institutional delivery scheme

A clinical photograph depicting a community-based maternal and child healthcare outreach setting in Mumbai, India. The image shows a group of women and a young child, with a female eye care worker positioned in the foreground on the right. The healthcare worker is identified by her professional blue lanyard and identification badge, which includes a photo and text, worn over a traditional green and white patterned sari and white blouse. She is smiling, indicative of a supportive community engagement role. Adjacent to her, a mother holds an infant dressed in a white shirt; the infant is positioned supine and appears to be under observation or receiving community-level postnatal support. This image illustrates the delivery of primary health services, specifically community eye care and maternal-child health screening, by trained local health workers within residential urban environments. It highlights concepts of healthcare accessibility, community health workers (CHWs), and primary prevention in global health contexts.

A clinical photograph depicting a healthcare training session in a primary health center in Karnataka, India. The image shows a nurse mentor, dressed in a red top and patterned garment, providing clinical support and instruction to two staff nurses. The staff nurses are wearing traditional white uniforms with white scarves. They are engaged in a case sheet audit, with one nurse actively writing on a patient medical record while the mentor points to specific documentation sections. This interaction illustrates quality improvement processes and provider skill upgrading through bedside case reviews and modeling of good practices. In the background, other individuals, including a child and a woman, are visible in the clinical environment. The photograph serves as an educational example of maternal and neonatal health mentoring interventions in rural, low-resource settings, focusing on improving the accuracy of clinical documentation and the quality of institutional delivery care.

This clinical photograph depicts a community healthcare setting in India, representative of primary care delivery and Health Technology Assessment (HTA) implementation at the ground level. The image shows a group of women, dressed in traditional saris, seated within a functional clinical ward or waiting area. The environment is equipped with essential medical furniture, including metal examination beds or cots and a wheelchair visible in the background. The walls are densely populated with educational posters and health charts, many of which utilize local regional scripts (Kannada) for public health communication. This visual illustrates the infrastructure of public health centers in federal healthcare systems, highlighting the interface between medical services and the community. Key educational concepts include global health systems, public health education, and the socio-cultural context of healthcare delivery in low-to-middle-income countries.

I have all the information needed. Let me now write the story AND generate a visual image together.

Generating Image

A detailed educational infographic about Janani Suraksha Yojana (JSY) India, showing: title at top "Janani Suraksha Yojana (JSY) - Mother's Protection Scheme", a pregnant woman with ASHA worker on left side, two columns showing Low Performing States (LPS) and High Performing States (HPS) cash amounts in rupees, a table showing Rural vs Urban cash incentives (Mother's package + ASHA package), key features listed as bullet points including "Launched April 12 2005", "100% Centrally Sponsored", "BPL families focus", "10 LPS states listed", color coded sections in green for rural and blue for urban, icons showing hospital building, cash/money, and mother with baby. Clean medical education poster style with warm orange and teal color scheme.

Here is the complete story + visual guide for Janani Suraksha Yojana (JSY):

The Story of Savitri and the Scheme That Protected Mothers

Chapter 1: The Problem - Mothers Were Dying at Home

In a village in Uttar Pradesh lived Savitri, a pregnant woman from a BPL (Below Poverty Line) family. Her mother-in-law insisted she deliver at home like generations before her. The nearest government hospital was 10 km away. There was no money for transport, no one to escort her, and no trust in institutions.

This was the reality across India - especially in states like UP, Bihar, Rajasthan, Madhya Pradesh, and others - where maternal and neonatal deaths were alarmingly high because women were simply not reaching hospitals.

The Government of India thought: "How do we change this? How do we make a poor woman WANT to deliver in a hospital?"

The answer - give her money to do it.

Chapter 2: The Birth of JSY - April 12, 2005

The old National Maternity Benefit Scheme was transformed into something far bigger and smarter - the Janani Suraksha Yojana (JSY), launched on 12th April 2005 under the National Rural Health Mission (NRHM).

JSY = Mother's Protection Scheme

Two clear objectives:

Reduce Maternal Mortality
Reduce Neonatal Mortality

...by encouraging women to deliver in health institutions and focusing care on BPL families.

It is a 100% Centrally Sponsored Scheme - meaning the central government funds it entirely.

Chapter 3: India Gets Divided into Two Groups - LPS vs HPS

Not all states were equal. Some states had very low rates of institutional delivery - they needed more push, more incentive.

India divided all states into two categories:

🔴 Low Performing States (LPS) - 10 States

These states had low institutional delivery rates and needed extra attention:

Uttar Pradesh, Uttarakhand, Madhya Pradesh, Jharkhand, Bihar, Rajasthan, Chhattisgarh, Odisha, Assam, Jammu & Kashmir

Special benefit in LPS: Cash assistance extended up to the 3rd child - but only if the mother voluntarily undergoes sterilization immediately after delivery at the health facility.

🟢 High Performing States (HPS)

All other states - where institutional delivery rates were already better.

Benefit in HPS: Only up to 2 live births (and only for BPL/SC/ST women).

Chapter 4: The Money - Who Gets What

This is where JSY becomes truly memorable. Think of it as two envelopes - one for the mother, one for the ASHA worker.

The Cash Table (from 2012-13 onwards):

Category	Rural - Mother	Rural - ASHA	Rural Total	Urban - Mother	Urban - ASHA	Urban Total
LPS	₹1,400	₹600	₹2,000	₹1,000	₹400	₹1,400
HPS	₹700	₹600	₹1,300	₹600	₹400	₹1,000

Memory trick: LPS gets MORE money because they need MORE push. Rural gets MORE than urban because rural women face more barriers.

Chapter 5: The ASHA - Savitri's Guardian Angel

Savitri had never heard of JSY until Meena-bai, the village's ASHA (Accredited Social Health Activist) knocked on her door.

Meena-bai's job under JSY was clear:

Identify BPL pregnant women like Savitri
Arrange institutional antenatal care for her
Escort her to the health centre for delivery
Arrange referral transport (minimum ₹250 for transport)
Do a post-natal visit to Savitri after delivery
Ensure BCG vaccination of the newborn 7Get paid only AFTER the post-natal visit + BCG immunization (minimum ₹200 per delivery, rest as balance)

The ASHA package is available in:

All 10 LPS states
All North-East states
Tribal districts of all states and UTs

Chapter 6: Who is Eligible? - The Eligibility Rules

In Low Performing States (LPS):

ALL women - whether BPL or not - delivering in government health centres (Sub-centre, PHC, CHC, FRU, District Hospital) or accredited private institutions are eligible. SC and ST women are included.

In High Performing States (HPS):

Only BPL women + SC/ST pregnant women delivering in government or accredited private institutions are eligible.

Chapter 7: Home Delivery - Even That is Covered

What if Savitri still insisted on delivering at home?

JSY has an answer for that too. ALL BPL women in both LPS and HPS who prefer home delivery are entitled to:

₹500 cash assistance per delivery - regardless of age and number of children.

No woman is left completely uncovered.

Chapter 8: The Caesarean Subsidy - For Complicated Cases

When complications arise and a woman needs a C-section but the government specialist is unavailable, JSY subsidizes:

Up to ₹1,500 per delivery to government institutions for caesarean section and obstetric complication management.

Chapter 9: 2006-07 - The Year of Institutional Deliveries

The Government declared 2006-07 as the Year for Institutional Deliveries. That year:

Scheme extended to urban areas of High Performing States
Age and birth-order restrictions removed in LPS
Benefits extended to all SC/ST women for institutional deliveries

Chapter 10: Direct Benefit Transfer - Money Goes Straight to Savitri

No middlemen. No delays. Under the Direct Benefit Transfer (DBT) system:

Eligible pregnant women receive JSY cash directly into their Aadhaar-linked bank account or via electronic fund transfer (EFT).

Chapter 11: The Impact - Crores of Mothers Helped

Since inception of NRHM: 8.55 crore women benefited under JSY
In 2018-19 alone: 100.41 lakh (1 crore+) pregnant women benefited

Savitri was one of them. She delivered safely at the PHC, received ₹1,400, Meena-bai got ₹600, the baby was vaccinated with BCG, and both went home healthy.

Quick Memory Summary

Feature	Key Detail
Launched	12 April 2005
Modified from	National Maternity Benefit Scheme
Under	NRHM
Funding	100% Central Government
Objective	Reduce MMR + NMR via institutional delivery
LPS states	10 (UP, UK, MP, JH, BR, RJ, CG, OD, AS, J&K)
LPS Rural (Mother)	₹1,400
LPS Urban (Mother)	₹1,000
HPS Rural (Mother)	₹700
HPS Urban (Mother)	₹600
ASHA Rural	₹600 (all LPS)
ASHA Urban	₹400
Home delivery (BPL)	₹500 (all states)
C-section subsidy	Up to ₹1,500
Birth limit - LPS	Up to 3rd child (with sterilization)
Birth limit - HPS	Up to 2 live births
Payment mode	Direct Benefit Transfer (DBT) via Aadhaar
Year of institutional deliveries	2006-07

Source: Park's Textbook of Preventive and Social Medicine, p. 514-515

Epidemiology of Blindness - discuss, National Programme for Control of Blindness in India* - describe*; Preventable Blindness in India - important causes

Finding Sources

Searching the Web

National Programme for Control of Blindness India NPCB epidemiology preventable blindness causes 2024

Finding Sources

Reading File

Finding Sources

Reading File

Searching Images

cataract blindness India eye surgery prevention causes epidemiology

This clinical photograph displays an elderly male patient in a rural, resource-limited setting, specifically Burkina Faso, post-ophthalmic intervention. The patient's left eye is occluded with a white surgical adhesive bandage, typically indicative of immediate postoperative care following sight-restoring procedures such as cataract surgery or trichiasis repair. The surrounding facial skin shows significant solar elastosis and dermatological aging, consistent with chronic ultraviolet exposure in a tropical climate. The image illustrates the delivery of primary eye health care and specialized surgical outreach in remote communities. The background features a thatched-roof dwelling and mountainous agricultural landscape, emphasizing the socioeconomic and geographical barriers to healthcare access. This visual is used to demonstrate the impact of community-based ophthalmology and public health initiatives in preventing avoidable blindness in underserved populations.

A multi-panel medical figure illustrating pediatric ophthalmological pathology and surgical intervention. The top row contains two clinical photographs of child eyes showing causes of treatable blindness: the left panel displays bilateral congenital cataracts, characterized by dense leukocoria (white pupillary reflex); the right panel depicts bilateral corneal opacities, presenting as diffuse clouding and scarring of the corneal stroma. The bottom row showcases stages of cataract surgery and intraocular lens (IOL) implantation. The bottom-left panel shows a surgeon utilizing an operating microscope. The bottom-middle panel provides an intraoperative close-up of a dilated pupil with a dense cataractous lens held by a speculum. The bottom-right panel displays the postoperative appearance after cataract extraction and successful implantation of an artificial IOL, restoring clear visual axes. This progression serves as a clinical example of surgical remediation for congenital vision impairment.

This intraoperative clinical photograph captures a human eye during cataract surgery, specifically demonstrating a rare acute opacification of an implanted trifocal intraocular lens (IOL). The image shows the anterior segment of the eye held open by surgical retractors, with a well-dilated pupil. Centered within the pupillary aperture, the implanted IOL optic exhibits a distinct, diffuse cloudiness or 'foggy' appearance, transitioning from its expected transparency to a semi-opaque white state. This phenomenon, often related to temperature fluctuations or material calcification, completely obscures the view of the posterior capsule. The surrounding iris and conjunctiva appear slightly hyperemic, typical of an ongoing surgical procedure. The photograph serves as a critical educational example of intraoperative IOL complications and material instability, highlighting the need for lens explantation when optical clarity is compromised immediately upon insertion.

I now have all the rich textbook data. Let me read the NPCB section which was in the truncated output.

Reading File

Now let me get the NPCB details from chapter 7:

Finding Sources

Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC3562965

I now have comprehensive information from both the textbook and PMC. Let me compile the full detailed answer.

Epidemiology of Blindness, NPCB, and Preventable Blindness in India

PART 1: EPIDEMIOLOGY OF BLINDNESS

Definition

WHO Definition: Blindness = Visual acuity of less than 3/60 (Snellen) or its equivalent.

India updated its definition in 2018 to align with WHO:

Old definition (1976): Unable to count fingers at 6 metres
New definition: Unable to count fingers at 3 metres
Effect: Blind population estimate reduced from 1.20 crore → 80 lakh

ICD-11 (2018) Classification of Vision Impairment

Distance Vision:

Category	Visual Acuity
Mild	Worse than 6/12
Moderate	Worse than 6/18
Severe	Worse than 6/60
Blindness	Worse than 3/60

Near Vision Impairment: Presenting near acuity worse than N6 or M0.8 at 40 cm.

Global Magnitude

1 billion people globally have preventable/unaddressed vision impairment (WHO 2020)
80% of all blindness is avoidable (treatable or preventable)
Major global causes of moderate-severe vision impairment:
1. Uncorrected refractive errors - 53%
2. Unoperated cataract - 25%
3. Age-related macular degeneration
4. Glaucoma - 6.9 million
5. Corneal opacities - 4.2 million
6. Diabetic retinopathy - 3 million
7. Trachoma - 2 million
8. Presbyopia (near) - 826 million

Magnitude in India

Survey	Prevalence
National Blindness Survey 2006-07	1.0%
National Survey 2015-19 (projected)	0.36%

India has 12 million blind persons out of 45 million globally
Blindness has declined due to NPCB, improved eye care access, and socioeconomic development

Causes of Blindness in India (National Survey 2015-19)

Cause	Percentage
Cataract (untreated)	66.2%
Cataract surgical complications	7.2%
Non-trachomatous corneal opacity	7.4%
Other posterior segment disease	5.9%
Glaucoma	5.5%
Phthisis	2.8%
Diabetic retinopathy	1.2%
Aphakia uncorrected	1.7%
Trachomatous corneal opacity	0.8%
ARMD	0.7%
Refractive error	0.1%
All other globe/CNS abnormalities	0.5%

Key: Cataract alone causes 2/3 of all blindness in India. Senile cataract occurs a decade earlier in India compared to Europe/America.

Epidemiological Determinants

(a) Age

30% of the blind in India lose vision before age 20; many before age 5
Children/Young: Refractive error, trachoma, conjunctivitis, Vitamin A deficiency (xerophthalmia)
Middle age: Cataract, refractive error, glaucoma, diabetes
All ages: Accidents/injuries (especially ages 20-40)

(b) Sex

Higher prevalence in females than males
Attributed to higher prevalence of trachoma, conjunctivitis, and cataract in women

(c) Malnutrition

Vitamin A deficiency causes keratomalacia - severe blinding corneal destruction
Mainly affects children aged 6 months to 3 years (up to 4-6 years)
PEM (Protein-Energy Malnutrition) also associated
Precipitated by measles and diarrhoea (cause malnutrition)

(d) Occupation

Factory/workshop workers at risk from: dust, flying objects, gases, radiation (UV, welding flash, X-rays)
Doctors/workers exposed to X-rays, UV rays, heat waves → premature cataract

(e) Social Class

Blindness is twice more prevalent in lower socio-economic groups
Poor nutrition, poor hygiene, limited access to eye care

Emerging Cause: Retinopathy of Prematurity (ROP)

Increasing because survival of premature babies (<30 weeks gestation, <1500g) has improved with NICUs
These babies are at high risk of ROP
Urgent need for awareness among ophthalmologists and paediatricians

PART 2: NATIONAL PROGRAMME FOR CONTROL OF BLINDNESS (NPCB) / NPCBVI

Background

India was the first country in the world to launch a national programme for blindness control
Launched: 1976 under the Ministry of Health and Family Welfare
100% Centrally Sponsored Scheme
Trachoma Control Programme (started 1963) was merged into NPCB in 1976
Renamed (2018): NPCB → National Programme for Control of Blindness and Visual Impairment (NPCBVI)
1983 National Health Policy target: Reduce prevalence from 1.4% to 0.3%
Current target: Reduce to 0.25% by 2025

Objectives of NPCB

Reduce the backlog of blindness through identification and treatment
Develop comprehensive eye care facilities in every district
Develop human resources for eye care services
Improve quality of service delivery
Secure participation of voluntary organizations and private practitioners
Enhance community awareness on eye care
Provide best possible treatment for curable blindness at district/regional level
Set up mechanisms for referral coordination and feedback

Strategies / Components

1. Primary Eye Care

Village Health Guides + Multipurpose Workers trained to handle:
- Acute conjunctivitis, ophthalmia neonatorum, trachoma, superficial foreign bodies, xerophthalmia
Equipped with: topical tetracycline, Vitamin A capsules, eye bandages/shields
Refer difficult cases (corneal ulcer, penetrating injuries, non-responsive infections) to PHC/District Hospital
Promote: personal hygiene, sanitation, good diet, safety
Coverage: 1 Village Health Guide / 1,000 population; 2 MPWs / 5,000 population

2. Secondary Care (District Level)

PHCs and District Hospitals with eye departments/clinics
Manages: Cataract, trichiasis, entropion, ocular trauma, glaucoma
Eye Camp Approach - highly successful for cataract surgery outreach
Mobile Eye Clinics - bring services to remote areas
Early detection surveys + health education

3. Tertiary Care (National/Regional Level)

Medical colleges and institutes for complex procedures:
- Retinal detachment surgery
- Corneal grafting (Eye Banks established under Corneal Grafting Acts)
- Complex surgical management
National Institute for the Blind, Dehradun - established for rehabilitation, new strategies

4. Specific Disease Programmes

Trachoma Control - mass campaigns with topical tetracycline
School Eye Health Services - early detection of visual defects in children
Eye Donation - Eye Donation Fortnight: 25th August to 8th September every year
- Leading states: Gujarat, Tamil Nadu, Maharashtra, Delhi, Chandigarh, AP, Kerala, Karnataka

5. Expanded Scope (Beyond Cataract - Recent)

NPCB now funds management of:

Diabetic Retinopathy (DR)
Glaucoma
Ocular Trauma
Childhood Blindness
Keratoplasty
Squint
Low Vision
Retinopathy of Prematurity (ROP)

Vision 2020: The Right to Sight

Global initiative launched by WHO on 18th February 1999
Goal: Eliminate avoidable blindness
Focus conditions: Cataract, xerophthalmia/childhood blindness, refractive error and low vision, trachoma, corneal blindness
Centres around sight as a fundamental human right

Global Eye Health Action Plan 2014-2019

Goal: Reduce avoidable visual impairment as a global public health problem
5 principles: Universal access and equity, human rights, evidence-based practice, life course approach, empowerment of visually impaired
Target: Reduce avoidable visual impairment by 25% by 2019 from 2010 baseline
Three indicators of progress: (1) Prevalence and causes of visual impairment; (2) Eye care personnel numbers; (3) Cataract surgery rates

PART 3: PREVENTABLE BLINDNESS IN INDIA - IMPORTANT CAUSES

80-90% of blindness in India is either curable or preventable.

The concept of "Avoidable Blindness" = Preventable + Curable blindness.

1. Cataract (Most Important - 66.2%)

Single largest cause of blindness in India
Largely curable by surgery (IOL implantation)
Occurs a decade earlier in India than the West
Strategies: Eye camps, cataract surgery coverage, IOL programmes, district-level facilities
Subsidized by NPCB through PPP and government hospitals

2. Refractive Errors

Uncorrected refractive errors - mostly preventable/correctable with spectacles
Free spectacles for persons 40+ years in eye screening camps (from 2014 under NPCB)

3. Corneal Blindness (Non-trachomatous: 7.4% + Trachomatous: 0.8%)

Trachoma - preventable with tetracycline, SAFE strategy (Surgery, Antibiotics, Facial cleanliness, Environmental improvement)
Corneal ulcer - 6.5 million affected, 1.3 million eyes go blind annually in the region
Xerophthalmia (Vitamin A deficiency) - preventable with Vitamin A supplementation
Trauma and ocular injuries - preventable with safety measures

4. Glaucoma (5.5%)

Primary open-angle glaucoma more common (1.7%) than primary angle-closure (0.73%)
Slight female preponderance
Early detection through screening - treatable if caught early

5. Childhood Blindness

Xerophthalmia (Vitamin A deficiency)
Ophthalmia neonatorum
Congenital cataract
Retinopathy of Prematurity (ROP) - emerging cause
Measles complications
Strategies: Vitamin A supplementation, immunization (measles), school eye health services

6. Diabetic Retinopathy (1.2%)

Growing cause with rising diabetes prevalence
Preventable through diabetes control + regular retinal screening

7. Occupational Blindness

Preventable through safety goggles, shields, regulations
Industries: factories, welding, chemical exposure

Quick Summary Table

Topic	Key Fact
WHO definition of blindness	VA < 3/60
India's prevalence (2015-19)	0.36%
#1 cause in India	Cataract (66.2%)
Avoidable blindness	80-90%
NPCB launched	1976 (100% centrally sponsored)
India's distinction	First country to launch national blindness programme
1983 target	Reduce from 1.4% to 0.3%
2025 target	Reduce to 0.25%
Renamed to	NPCBVI (2018)
Eye Donation Fortnight	25 Aug - 8 Sep
Vision 2020 launched	18 Feb 1999 (WHO)
Most vulnerable sex	Females (more blindness prevalence)
Keratomalacia age group	6 months - 3 years
Senile cataract in India	Occurs 10 years earlier than West

Source: Park's Textbook of Preventive and Social Medicine, pp. 452-456; PMC: Verma R, 2011 (PMID: 3562965)

Create a visual poster comparing preventable causes of blindness in India

Generating Image

A detailed medical education poster titled "Preventable Causes of Blindness in India" with a dark navy blue background and bright clean design. At the top: bold white title "Preventable Causes of Blindness in India" with subtitle "National Survey 2015-19 | 80-90% of Blindness is Avoidable". Center of poster: a large pie chart or donut chart showing proportions with labeled segments and percentages: - Cataract (untreated) 66.2% - bright orange segment, largest - Cataract surgical complications 7.2% - amber - Non-trachomatous corneal opacity 7.4% - teal - Glaucoma 5.5% - purple - Other posterior segment 5.9% - blue - Diabetic Retinopathy 1.2% - red - Refractive error 0.1% - green - Others (phthisis, aphakia, trachoma, ARMD) remaining percent - grey Below the chart: a row of 6 icon boxes each showing a cause with icon, name, prevention method: 1. Cataract - eye with cloudy lens icon - "Prevention: IOL Surgery, Eye Camps" 2. Refractive Error - spectacles icon - "Prevention: Free Spectacles" 3. Corneal Blindness - eye with scar icon - "Prevention: Tetracycline, Vit A" 4. Glaucoma - eye pressure icon - "Prevention: Early Screening" 5. Diabetic Retinopathy - blood glucose icon - "Prevention: Diabetes Control" 6. Childhood Blindness - child face icon - "Prevention: Vitamin A, Immunization" Bottom banner: "NPCB launched 1976 | Target: Reduce prevalence to 0.25% by 2025 | Vision 2020: The Right to Sight" Color scheme: navy background, orange and teal accents, white text, clean infographic medical poster style

Preventable Causes of Blindness in India - Visual Poster

Here is your visual poster on Preventable Causes of Blindness in India, summarizing data from the National Survey 2015-19.

Key highlights captured in the poster:

Cataract (66.2%) dominates as the single largest cause - and is fully curable with IOL surgery
80-90% of all blindness in India is avoidable - either treatable or preventable
Each cause is paired with its prevention/treatment strategy for quick revision
Bottom banner anchors the NPCB programme (launched 1976) and the target to reduce prevalence to 0.25% by 2025

The poster is designed for quick visual recall - ideal for exam revision. The pie chart proportions make it easy to remember that cataract alone accounts for roughly 2 out of every 3 blind persons in India.

RNTCP Programme of India* - describe salient features; three regimens of treatment under RNTCP - enumerate, Changes in RNTCP as compared to NTP, DOTS Strategy - five principles

RNTCP (Revised National Tuberculosis Control Programme) is India's main TB control strategy using DOTS. It was revised from the older NTP in 1997 and emphasizes sputum smear microscopy, short-course chemotherapy, and directly observed treatment.

Searching sources...

Finding Sources

Searching the Web

RNTCP India salient features DOTS strategy five principles treatment regimens NTP comparison

Finding Sources

Reading File

Now let me get the RNTCP salient features and NTP comparison from the same block:

Finding Sources

Reading Web Page

https://www.bionity.com/en/encyclopedia/RNTCP.html

I now have comprehensive data from both the textbook and web sources. Here is the complete, structured answer:

RNTCP - Revised National Tuberculosis Control Programme

PART 1: SALIENT FEATURES OF RNTCP

Background and History

Milestone	Year
National TB Programme (NTP) launched	1962
RNTCP pilot started	1993
RNTCP launched as national programme	1997
Rapid expansion begins	Late 1998
30% population coverage	End of 2000
50% population coverage	End of 2002
778 million covered	End of 2003
997 million covered	End of 2004
~97% (1080 million) covered	December 2005
Entire country covered	24 March 2006
Renamed to NTEP (National TB Elimination Programme)	2020

India's goal: End TB by 2025 (5 years ahead of global 2030 target)

Salient Features of RNTCP

State-run TB Control Initiative - Government of India programme
100% free anti-TB drugs provided across the country through PHCs and private-sector DOTS providers
Incorporates the WHO-recommended DOTS strategy
Decentralized organizational structure - services available at peripheral level
Diagnosis based primarily on sputum smear microscopy (ZN staining) - X-ray plays a secondary role
Three sputum samples collected over 2 days (Spot-Morning-Spot) → ensures >99% test sensitivity
Standardized treatment regimens based on patient category (I, II, III)
Drugs provided in patient-wise boxes with sufficient shelf-life
Multi-blister combipacks - weekly supply in continuation phase to track compliance
Pharmacovigilance system integrated for adverse drug reaction monitoring
Nikshay portal - online platform for patient notification, tracking, and treatment outcome recording
Focus on sputum-positive pulmonary TB (highest public health priority - spreads disease)
Public-Private Partnership (PPP) - private sector DOTS providers included
Expanded to cover: DR-TB, HIV-TB, Childhood TB, new drugs (Bedaquiline, Delamanid)

PART 2: DOTS STRATEGY - FIVE PRINCIPLES

DOTS = Directly Observed Treatment, Short-Course

DOTS is the only strategy documented to be effective worldwide on a programme basis. It ensures cure by providing the most effective medicines and confirming they are actually swallowed.

The Five Principal Components of DOTS:

No.	Component	Detail
1	Political and administrative commitment	Sustained government support and funding at national, state, district levels
2	Case detection by Sputum Smear Microscopy	ZN staining - primary diagnostic tool; 3 samples over 2 days (Spot-Morning-Spot)
3	Uninterrupted supply of good quality anti-TB drugs	Patient-wise boxes, multi-blister combipacks, proper storage and supply chain
4	Standardized treatment regimens with directly observed treatment for at least the first 2 months	Health worker watches patient swallow drugs in IP; continuation phase checked by empty combipack return
5	Systematic monitoring and accountability	Recording and reporting system, Nikshay portal, treatment outcome tracking

How DOTS Works in Practice:

Intensive Phase (IP): A health worker or trained person physically watches the patient swallow every dose
Continuation Phase (CP): Patient issued medicine for one week in a multi-blister combipack; first dose swallowed in front of health worker; empty combipack returned when collecting next week's supply = proof of consumption

PART 3: THREE TREATMENT REGIMENS UNDER RNTCP

(Original RNTCP categorization - still asked in exams)

Patients classified into 3 Categories based on:

Nature/severity of disease
History of previous anti-TB treatment

Category I

Who: New sputum smear-positive TB + Seriously ill smear-negative + Seriously ill extra-pulmonary TB

Regimen:

2H₃R₃Z₃E₃ + 4H₃R₃

Phase	Duration	Drugs	Frequency
Intensive Phase	2 months	HRZE (Isoniazid + Rifampicin + Pyrazinamide + Ethambutol)	Thrice weekly
Continuation Phase	4 months	HR (Isoniazid + Rifampicin)	Thrice weekly
Total duration	6 months

Category II

Who: Sputum smear-positive Relapse + Sputum smear-positive Failure + Sputum smear-positive Treatment after Default

Regimen:

2H₃R₃Z₃E₃S₃ + 1H₃R₃Z₃E₃ + 5H₃R₃E₃

Phase	Duration	Drugs	Frequency
Intensive Phase	2 months	HRZES (H+R+Z+E+Streptomycin)	Thrice weekly
Extended IP	1 month	HRZE (without Streptomycin)	Thrice weekly
Continuation Phase	5 months	HRE	Thrice weekly
Total duration	8 months

Key: Streptomycin added in first 2 months of IP

Category III

Who: New sputum smear-negative, NOT seriously ill + New extra-pulmonary, NOT seriously ill

Regimen:

2H₃R₃Z₃ + 4H₃R₃

Phase	Duration	Drugs	Frequency
Intensive Phase	2 months	HRZ	Thrice weekly
Continuation Phase	4 months	HR	Thrice weekly
Total duration	6 months

Drug Code Key:

Letter	Drug
H	Isoniazid (INH)
R	Rifampicin
Z	Pyrazinamide
E	Ethambutol
S	Streptomycin
Subscript 3	Thrice weekly
Prefix number	Duration in months

PART 4: CHANGES IN RNTCP COMPARED TO NTP

National TB Programme (NTP) - 1962 (Old)

Feature	NTP (Old)
Case finding	Passive - X-ray based (secondary)
Diagnosis	X-ray + sputum (variable)
Treatment	Long-course (12-18 months), self-administered
Drug regimens	Non-standardized, often irregular
Supervision	No direct observation of treatment
Drug supply	Often irregular/insufficient
Focus	Less priority to smear-positive cases
Private sector	Not involved
Monitoring	Weak recording and reporting

RNTCP - 1997 (Revised)

Feature	RNTCP (New)
Case finding	Active + passive; sputum smear-based
Diagnosis	Sputum smear microscopy PRIMARY tool (ZN/LEDFM)
Treatment	Short-course chemotherapy (6-8 months)
Drug regimens	Standardized (Cat I, II, III)
Supervision	DOTS - Directly Observed Treatment
Drug supply	Patient-wise boxes, multiblister combipacks
Focus	Priority to smear-positive cases (source of infection)
Private sector	PPP - private DOTS providers included
Monitoring	Nikshay, systematic recording and reporting

Key Changes: NTP → RNTCP Summary

Aspect	NTP	RNTCP
Diagnostic tool	X-ray primary	Sputum smear primary
Treatment duration	12-18 months	6-8 months (short-course)
Drug supervision	Self-administered	Directly observed (DOTS)
Drug supply	Irregular	Regular patient-wise boxes
Categories	Not standardized	Three categories (I, II, III)
Drugs frequency	Daily	Thrice-weekly intermittent (original; now switched to daily FDC under NTEP 2016)
Coverage	Incomplete	Nationwide by March 2006
HIV-TB	Not addressed	Integrated TB-HIV activities
DR-TB	Not managed	Programmatic MDR-TB Management (PMDT)
New drugs	None	Bedaquiline, Delamanid (from 2016)

PART 5: CURRENT UPDATE - NTEP (2020 onwards)

RNTCP has now been rechristened NTEP (National TB Elimination Programme) with key changes:

Change	RNTCP	NTEP
Treatment schedule	Thrice-weekly (intermittent)	Daily fixed dose combinations (FDC)
Diagnosis basis	Category-based (Cat I/II/III)	Drug susceptibility testing (DST) first
Patient classification	Category I/II/III	Drug-sensitive TB / DR-TB (based on DST results)
Regimen for DS-TB	2HRZE + 4HR (thrice weekly)	2HRZE + 4HRE (daily)
DR-TB treatment	Standard second-line	Individualized + fully oral regimens preferred
Injectables in MDR-TB	Used	No longer priority - oral regimens preferred
Goal	Reduce burden	End TB by 2025

Quick Memory Table

Feature	Key Fact
NTP launched	1962
RNTCP pilot	1993
RNTCP national launch	1997
Full coverage	24 March 2006
Renamed NTEP	2020
DOTS =	Directly Observed Treatment, Short-course
DOTS principles	5 (Commitment, Microscopy, Drug supply, Standardized regimen+DOT, Monitoring)
Cat I regimen	2HRZE + 4HR
Cat II regimen	2HRZES + 1HRZE + 5HRE
Cat III regimen	2HRZ + 4HR
Sputum samples	3 (Spot-Morning-Spot)
IP supervision	Direct observation (health worker present)
CP supervision	Multiblister combipack return
India's TB goal	End TB by 2025

Sources: Park's Textbook of Preventive and Social Medicine, pp. 218-222; RNTCP guidelines; NTEP Technical Guidelines 2016 & 2019

Tell me in story format

The Story of Raju's Cough - India's War Against TB

Chapter 1: The Old Enemy That Wouldn't Leave

India has always had a complicated relationship with Tuberculosis (TB). For centuries, it was called "Rajrog" - the King's Disease - but there was nothing royal about the suffering it caused. By the mid-20th century, TB was killing lakhs of Indians every year.

In 1962, the Government finally said "Enough" and launched the National TB Programme (NTP) - India's first formal war against TB.

But the war wasn't going well.

Chapter 2: The NTP - Good Intentions, Weak Execution

In a small district hospital, a doctor named Dr. Rao was trying to treat TB patients under NTP.

The problems were everywhere:

Patients were diagnosed mainly by X-ray - which was expensive, unreliable, and not widely available in villages
Treatment lasted 12 to 18 months - far too long for poor patients to stay compliant
Drugs were given to patients to take at home, unsupervised - and most stopped midway when they felt better
Drug supply was irregular - medicines ran out constantly
There was no standardized regimen - each doctor prescribed differently
No one tracked whether patients actually got cured or not

Raju's father had TB in 1970 under NTP. He started treatment, felt better after 3 months, stopped taking medicines, relapsed, and this time the bacteria had become resistant.

"The disease wasn't just surviving - it was adapting and growing stronger."

NTP was failing. India needed a revolution.

Chapter 3: The WHO Sends Help - DOTS is Born

In the 1980s and early 1990s, a global consensus emerged. The WHO developed a strategy that had been proven to work in multiple countries - it was called DOTS: Directly Observed Treatment, Short-Course.

The idea was beautifully simple:

"Don't trust the patient to take medicines alone. Watch them swallow every single dose."

India noticed. And in 1993, a pilot project was started in just a few districts to test DOTS.

The results were extraordinary. Cure rates shot up. Drug resistance dropped. The model worked.

Chapter 4: RNTCP is Born - 1997

On the strength of the pilot results, India launched the Revised National Tuberculosis Control Programme (RNTCP) in 1997 - incorporating DOTS as its backbone.

The word "Revised" was deliberate. This wasn't the old NTP with a few tweaks. This was a complete overhaul.

The coverage march was rapid:

End of 2000: 30% of India covered
End of 2002: 50% covered
End of 2003: 778 million covered
End of 2004: 997 million covered
December 2005: 97% covered
24th March 2006: The ENTIRE country - 1,114 million people - covered under DOTS

India had done something remarkable. A programme launched as a pilot in 1993 had covered one billion people in just over a decade.

Chapter 5: The Five Pillars of DOTS - The Soul of RNTCP

RNTCP ran on five non-negotiable pillars. Think of them as the five legs of a stool - without even one, the whole thing collapses.

Pillar 1 - Political and Administrative Commitment

"The government must want this."

The PM's office, Health Ministry, State governments, District health officials - all had to be aligned and fund the programme consistently. Free drugs. Free diagnosis. No excuses.

Pillar 2 - Case Detection by Sputum Smear Microscopy

"Find the right patient. The one who is actually spreading the disease."

Under NTP, X-ray was the primary tool. Under RNTCP, sputum smear microscopy (ZN staining) became the gold standard - cheaper, faster, and more specific.

3 sputum samples were collected over 2 days in a Spot-Morning-Spot pattern. Three samples ensured a sensitivity of over 99%.

Why focus on sputum-positive patients? Because they are the active spreaders - the ones coughing bacteria into the air. Find them, treat them, and the chain of transmission breaks.

Pillar 3 - Uninterrupted Supply of Good Quality Anti-TB Drugs

"No excuses about drugs running out."

Every patient got a patient-wise box - a box containing ALL their drugs for the entire treatment duration - labelled with their name, with sufficient shelf life.

Drugs came in multi-blister combipacks for the continuation phase - one week's supply per pack.

No stockouts. No excuses.

Pillar 4 - Standardized Treatment with Direct Observation (at least first 2 months)

"Watch every dose go down the throat."

This is the heart of DOTS.

Intensive Phase: A health worker - or any trained person - physically sat with the patient and watched them swallow every dose of medicine. No exceptions.

Continuation Phase: The patient collected medicine weekly (one multi-blister combipack). The FIRST dose was swallowed in front of the health worker. When the patient came next week, they had to return the EMPTY combipack - proof that all doses were taken.

Clever. Simple. Effective.

Pillar 5 - Systematic Monitoring and Accountability

"Track every patient. Know every outcome."

Every TB patient was registered and tracked through standardized recording and reporting forms - and later through the Nikshay portal (India's online TB notification system).

Treatment outcomes were classified: Cured, Treatment Completed, Failed, Defaulted, Died, Transferred. Numbers were reported up from sub-centre → PHC → District → State → Centre.

No patient fell through the cracks silently.

Chapter 6: Raju Gets TB - The Three Treatment Categories

Thirty years after his father's failed treatment, Raju himself developed TB. He came to the same district hospital - but this time, everything was different.

Under RNTCP, every TB patient was classified into one of three Categories based on two things:

How sick are they?
Have they been treated before?

Category I - "The New Sick Patient"

Raju had:

Positive sputum smear (first time, new case)
Coughing for 3 weeks

He was classified as Category I.

His regimen:

2H₃R₃Z₃E₃ + 4H₃R₃

Phase	Duration	Drugs	How often
Intensive Phase	2 months	H + R + Z + E (4 drugs)	Thrice weekly
Continuation Phase	4 months	H + R (2 drugs)	Thrice weekly
Total	6 months

The health worker Sunita came to Raju's house every Monday, Wednesday, and Friday. She watched him swallow. She recorded it. She never missed a day.

Category II - "The Relapse or Failed Patient"

Raju's neighbour Mohan had previously been treated for TB. He had stopped midway, relapsed, and came back to the clinic with a positive sputum smear.

Mohan needed a stronger regimen - Category II.

His regimen:

2H₃R₃Z₃E₃S₃ + 1H₃R₃Z₃E₃ + 5H₃R₃E₃

Phase	Duration	Drugs	Note
Intensive Phase	2 months	H+R+Z+E+S (Streptomycin)	Extra drug added
Extended IP	1 month	H+R+Z+E	Streptomycin stopped
Continuation Phase	5 months	H+R+E
Total	8 months

Streptomycin injection was added for the first 2 months because Mohan's bacteria might already have some resistance. The extra punch was needed.

Category III - "The Mildly Ill New Patient"

Raju's young cousin Priya was found to have TB affecting her lymph nodes (extra-pulmonary), but her sputum was negative and she wasn't seriously ill.

She was classified as Category III - the mildest regimen.

Her regimen:

2H₃R₃Z₃ + 4H₃R₃

Phase	Duration	Drugs
Intensive Phase	2 months	H+R+Z (3 drugs)
Continuation Phase	4 months	H+R (2 drugs)
Total	6 months

Same duration as Cat I but one fewer drug in IP - because the bacillary load was lower.

Chapter 7: The Drug Alphabet - Quick Decoder

Letter	Drug	Special Memory
H	Isoniazid (INH)	"H for Haazir" - always present in every regimen
R	Rifampicin	"R for Red urine" - turns urine red, used to check compliance
Z	Pyrazinamide	"Z for last letter" - used in IP only
E	Ethambutol	"E for Eyes" - can cause optic neuritis
S	Streptomycin	"S for Serious relapse" - added in Cat II only
Subscript 3	Thrice weekly	"3 times a week"
Prefix number	Duration in months	2H = Isoniazid for 2 months

Chapter 8: How RNTCP Was Different From the Old NTP

Old Dr. Rao (who worked under NTP) visited the new RNTCP clinic in 2000 and couldn't believe the transformation:

He saw before (NTP)	He saw now (RNTCP)
X-ray machine queue	Sputum microscopy lab - fast, cheap
12-18 month treatment	6-8 month short-course
Patients taking drugs at home	Health worker watching every dose
Drugs running out	Patient-wise box - full course pre-packed
No standard regimen	Three categories - nationally standardized
No idea who was cured	Nikshay tracking every patient
Private sector excluded	PPP - private doctors as DOTS providers
TB-HIV not addressed	Integrated TB-HIV programme

"Same disease. Different war. Different outcome." Dr. Rao said.

Chapter 9: The Programme Evolves - From RNTCP to NTEP

By 2016-2020, India's TB programme evolved further. The old thrice-weekly intermittent regimens gave way to daily fixed-dose combinations (FDC) - where all drugs are combined into one tablet to swallow daily.

And in 2020, India retired the name RNTCP and rechristened the programme as:

NTEP - National TB Elimination Programme

Why "Elimination"? Because India set an audacious goal: End TB by 2025 - five years ahead of the global 2030 target.

Key changes under NTEP:

All patients get Universal Drug Susceptibility Testing (UDST) first
Treatment based on drug sensitivity results - not just categories
Daily FDC regimen replaces thrice-weekly
Fully oral regimens for MDR-TB (injections no longer mandatory)
New drugs: Bedaquiline (BDQ) and Delamanid (DLM) for resistant TB

Chapter 10: Raju is Cured

Six months later, Raju's sputum was negative. He had swallowed every dose under Sunita's watchful eye. He had not missed a single visit.

He was classified: CURED.

His father had failed treatment 30 years ago. Raju succeeded - not because the drugs were different, but because the system was different.

A health worker who watched every dose
Drugs that were always available
A government that was committed
A record that tracked his every step

That is RNTCP. That is DOTS. That is the difference between a programme that fails and one that saves lives.

Final Memory Map

Element	Key Fact
NTP	1962
RNTCP pilot	1993
RNTCP national	1997
Full coverage	24 March 2006
Renamed NTEP	2020
India's TB goal	End TB by 2025
DOTS =	5 Pillars
Cat I	New smear +ve → 2HRZE + 4HR (6 months)
Cat II	Relapse/Failure → 2HRZES + 1HRZE + 5HRE (8 months)
Cat III	New smear -ve mild → 2HRZ + 4HR (6 months)
Sputum samples	3 (Spot-Morning-Spot)
IP supervision	Direct observation every dose
CP supervision	Multiblister combipack return

Visualise me everthing with a image

I'll create multiple visual images covering every aspect of RNTCP/DOTS simultaneously!

Generating Image

A clean medical education infographic poster with dark teal background titled "RNTCP - India's TB Control Journey" showing a horizontal timeline arrow at the top with these milestones clearly labeled with year and event: 1962 NTP launched, 1993 RNTCP Pilot, 1997 RNTCP National Launch, 2006 Full Country Coverage (1114 million), 2020 Renamed NTEP, 2025 End TB Goal. Below the timeline: a large central box titled "RNTCP Key Facts" with white bullet points: "100% Free Anti-TB Drugs", "DOTS Strategy", "Sputum Smear Microscopy Primary Tool", "3 Sputum Samples - Spot Morning Spot", "Patient-wise Drug Boxes", "Nikshay Portal for tracking", "PPP - Private sector included". Bottom row shows India map with coverage statistics: 30% by 2000, 50% by 2002, 97% by 2005, 100% by March 2006. Color scheme: teal and gold on dark background, clean medical infographic style, white text

Generating Image

A vibrant medical education poster titled "DOTS - 5 Pillars Strategy" on deep navy blue background. Show 5 tall pillars or columns side by side, each pillar a different bright color, each with a number, icon, and text: Pillar 1 (Orange) - icon of government building - "Political Commitment" - "Sustained govt support and funding" Pillar 2 (Yellow) - icon of microscope - "Sputum Smear Microscopy" - "3 samples Spot-Morning-Spot, ZN staining, 99% sensitivity" Pillar 3 (Green) - icon of medicine box - "Uninterrupted Drug Supply" - "Patient-wise boxes, Multi-blister combipacks" Pillar 4 (Red) - icon of health worker watching patient - "Directly Observed Treatment" - "IP: Watch every dose. CP: Return empty combipack" Pillar 5 (Purple) - icon of checklist and computer - "Monitoring and Accountability" - "Nikshay portal, recording, reporting, treatment outcomes" Above all pillars: subtitle "DOTS = Directly Observed Treatment Short-Course". Below: "Only strategy proven effective worldwide on programme basis". Clean bold infographic style, white text on colored pillars

Generating Image

A detailed medical education table-style poster on white background titled "RNTCP - Three Treatment Categories" with bold red title bar. Three side-by-side colored sections: LEFT SECTION (Blue) - "Category I" - Who: New smear positive, Seriously ill smear negative, Seriously ill extrapulmonary. Regimen box showing: "Intensive Phase: 2 months HRZE (4 drugs) Thrice weekly" + "Continuation Phase: 4 months HR (2 drugs) Thrice weekly" + "Total: 6 months" - highlighted in blue MIDDLE SECTION (Orange) - "Category II" - Who: Relapse, Failure, Treatment after Default. Regimen: "Intensive Phase: 2 months HRZES (5 drugs with Streptomycin)" + "Extended IP: 1 month HRZE" + "Continuation: 5 months HRE" + "Total: 8 months" - highlighted in orange RIGHT SECTION (Green) - "Category III" - Who: New smear negative not seriously ill, New extrapulmonary not seriously ill. Regimen: "Intensive Phase: 2 months HRZ (3 drugs)" + "Continuation: 4 months HR" + "Total: 6 months" - green Bottom drug key table: H=Isoniazid, R=Rifampicin, Z=Pyrazinamide, E=Ethambutol, S=Streptomycin. Subscript 3 = Thrice weekly. Clean bold medical poster style

Generating Image

A split comparison medical education poster titled "NTP vs RNTCP - The Revolution in TB Control" with a bold vertical dividing line in the center. Left half with faded red background labeled "NTP - 1962 (Old)" and right half with bright green background labeled "RNTCP - 1997 (New)". Each side lists 8 comparison rows with icons: Row 1: Diagnosis - X-ray primary | Sputum smear microscopy PRIMARY Row 2: Treatment duration - 12-18 months | 6-8 months SHORT COURSE Row 3: Drug intake - Self-administered at home | DIRECTLY OBSERVED (health worker watches) Row 4: Drug supply - Irregular, ran out | Patient-wise boxes, always available Row 5: Regimens - Not standardized | 3 Categories - nationally standardized Row 6: Private sector - Excluded | PPP - private DOTS providers included Row 7: Monitoring - Weak/no tracking | Nikshay portal - every patient tracked Row 8: HIV-TB - Not addressed | Integrated TB-HIV activities Bottom banner: "Same disease. Better system. Better outcomes." Bold clear medical infographic style, red cross marks on left, green checkmarks on right

Error calling model 'gemini-3-pro-image' (RESOURCE_EXHAUSTED): 429 RESOURCE_EXHAUSTED. {'error': {'code': 429, 'message': 'Resource has been exhausted (e.g. check quota).', 'status': 'RESOURCE_EXHAUSTED'}}